CNR Institutional Research Information System

BERGHELLA, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.076
NA - Nord America 1.686
EU - Europa 444
SA - Sud America 397
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 3
Totale 4.657
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.619
SG - Singapore 893
CN - Cina 406
BR - Brasile 311
HK - Hong Kong 273
VN - Vietnam 191
FR - Francia 144
IT - Italia 135
KR - Corea 61
BD - Bangladesh 58
IN - India 42
JP - Giappone 41
CA - Canada 33
AR - Argentina 30
DE - Germania 28
GB - Regno Unito 28
NL - Olanda 26
ID - Indonesia 18
IQ - Iraq 15
MX - Messico 15
EC - Ecuador 14
FI - Finlandia 13
CO - Colombia 12
IL - Israele 12
SE - Svezia 12
VE - Venezuela 11
ES - Italia 9
TR - Turchia 9
PE - Perù 8
PK - Pakistan 8
ZA - Sudafrica 8
KE - Kenya 7
MA - Marocco 7
UA - Ucraina 7
JO - Giordania 6
MY - Malesia 6
PL - Polonia 6
SA - Arabia Saudita 6
IE - Irlanda 5
KZ - Kazakistan 5
RU - Federazione Russa 5
CL - Cile 4
HR - Croazia 4
LB - Libano 4
AT - Austria 3
AU - Australia 3
CR - Costa Rica 3
ET - Etiopia 3
JM - Giamaica 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
GE - Georgia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
TW - Taiwan 1
Totale 4.641
Salva come PNG Salva come JPEG
Città #
Santa Clara 721
Singapore 523
Hong Kong 269
Hefei 147
San Jose 137
Ashburn 104
Lauterbourg 100
Beijing 98
Ho Chi Minh City 67
Los Angeles 62
Seoul 57
Hanoi 47
São Paulo 32
Dallas 31
Tokyo 31
New York 29
Buffalo 26
Phoenix 23
Da Nang 12
Helsinki 12
Milan 12
Brooklyn 11
Montreal 10
Stockholm 10
Chennai 9
Baghdad 8
Charlotte 8
Chicago 8
Dhaka 8
Frankfurt am Main 8
Houston 8
Minamishinagawa 8
Orem 8
Rio de Janeiro 8
Rome 8
Mumbai 7
Newark 7
Quito 7
Atlanta 6
Belo Horizonte 6
Bengaluru 6
Düsseldorf 6
Haiphong 6
Johannesburg 6
Kuala Lumpur 6
Miami 6
Nairobi 6
Nuremberg 6
Philadelphia 6
Porto Alegre 6
Baltimore 5
Campinas 5
Dublin 5
Queens 5
Riyadh 5
Toronto 5
Amman 4
Biên Hòa 4
Bogotá 4
Boston 4
Brasília 4
Canyon Country 4
Casablanca 4
Council Bluffs 4
Fort Lauderdale 4
Guangzhou 4
Jacksonville 4
Jakarta 4
Lima 4
London 4
Marigliano 4
Portsmouth 4
Seattle 4
Shanghai 4
Thái Bình 4
Warsaw 4
Addis Ababa 3
Almaty 3
Araruama 3
Austin 3
Can Tho 3
Caracas 3
Charleston 3
Cincinnati 3
Contagem 3
Curitiba 3
Denver 3
Fort Worth 3
Genoa 3
Guayaquil 3
Hangzhou 3
Kyiv 3
Las Vegas 3
Mexico City 3
Montevideo 3
Nanjing 3
Nha Trang 3
Ourinhos 3
Pescara 3
Scottsdale 3
Totale 2.935
Salva come PNG Salva come JPEG
Nome #
Classification of cancer stage using the immune system. 100
Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? 95
Analisi longitudinale delle sottopopolazioni T-linfocitarie nella Sclerosi Multipla. 92
Personalized Prevention Strategies to Defeat Cancer 86
Immunological mechanisms in the establishment and progression of colon cancer. 77
Day of Immunology 2015 73
The definition of a panel of clinical biomarkers of homeostasis: a new promising tool for prevention and treatment of chronic-degenerative 69
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance. 67
Cytokines in colon cancer patients. 66
Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer 65
CD30 antigen: not a physiological marker for TH2 cells but animportant costimulator molecule in the regulation of the balance between TH1/TH2 response 64
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy 64
CD30 Molecule, The Immune System and Multiple Sclerosis. 62
Farmaci neurolettici e produzione di linfochine "in vitro" in pazienti schizofrenici. 59
Tumor stage and serum levels of sIL-2R in colon cancer patients 57
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. 54
Cytokines in colon cancer patients: Disease markers in cancer therapy. Il-2 receptor 52
Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer. 52
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age 51
Immunological directives for biotherapy improvement in the treatment of colorectal cancer. 50
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy 50
Medical research news in the understanding, diagnosis, treatment, cure or prevention of cancer disease: "ARE IMMUNOLOGICAL MECHANISMS INVOLVED IN COLON CANCER AND ARE THEY POSSIBLE MARKERS FOR BIOTHERAPY IMPROVEMENT?" 50
IL-8 involvement in immune disregulation of cancer patients 50
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy 49
Medical research news in the understanding, diagnosis, treatment, cure or prevention of human disease: "Ageing gender-specific targets/biomarkers for the identification of drugs with specific gender-related action and more appropriate therapeutic strategies." 48
Livelli serici di IL-2, sIL-2R, IL-6 and TNF nella schizofrenia: uno studio controllato 47
A gender-related action of IFNß-therapy was found in multiple sclerosis. 47
Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. 47
Correlazione tra gli alleli DPB1 ed MLC nel trapianto di rene 46
Identification of a recombination event by DNA heteroduplex in a bone marrow transplant familial study 45
Novel Prognostic Biomarkers for Personalized Cancer Treatment 45
IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer 44
Prognostic indices for the early classification of colon cancer stage 43
Prognostic indices for the early classification of colon cancer stage. 43
Soluble IL-2 Receptor and proliferative responses to IL-2+anti-CD3 monoclonal antibody in colon cancer 43
The study of patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. 43
Immunological mechanisms in the establishment and progression of colon caner 43
Marcatori di linfociti nell'anziano in emodialisi periodica 42
The immunological implications of gene alterations in the progression of colorectal cancer: indications for prognosis, treatment and tumor understanding. 42
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patients 42
Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer 42
Bcl-2 and drugs used in the treatment of cancer: New strategies of biotherapy which should not be underestimated. 41
Hypothesis of the variable clinical response to immunotherapeutic treatments in colon cancer patients 40
Cancer establishment and progression 40
IL-6 and NK activity in colorectal cancer. 39
Production of cytokines in schizophrenic patients: correlation with pharmacological treatment 39
Colon cancer: hypotesis of progression mechanism 39
Colon cancer: sIL-2R and correlated mechanisms 39
Progression mechanisms in colon cancer: soluble interleukin2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and 39
L'ipotesi autoimmunitaria della schizofrenia. Recettore solubile dell'Interleuchina 2 e Tumor Necrosis Factor. 39
The Significance of an increase in soluble interleukin- 2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 o TH2 and back. 39
MLC test and/or DNA typing in Bone Marrow transplantation 38
DETECTION OF CIRCULATING ICAM-1 AND SOLUBLE IL-2 RECEPTOR IN SERUM OF COLORECTAL CANCER PATIENTS 37
HLA and policystic disease: a negative association 37
Immunological implications of alterations in the c-ki-ras and p53 gene in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding. 37
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patienst 37
HLA antigens in multiple sclerosis 36
IFNbeta-1a treatment and reestablishment of TH1 regulation in MS patients: dose effects. 36
In vitro evaluation of the immunological response in colon cancer patients: effects of IL-2, IL-4 and anti-CD3MoAb 36
Blockade of N Methyl D-Aspartate receptor prevents Hypoxic Neuronal dath and Cytokine release. 36
Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions 36
Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression 35
Serum factor may interact with T8+ cells during the clinical course of multiple sclerosis. 35
Cytokines in Schizophrenia 35
Immune disregulation in colon cancer 35
Andamento dell'HBSAg e dell'HbsAb nei pazienti e nel personale di alcune centrali dialitiche. 34
Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules 34
Simultaneous measurement of sCEA and TIMP1 serum levels for use as pre-invasive to invasive markers of colorectal cancer. 34
Role of HLA-restricted T cells in colorectal cancer 34
Monitoraggio serico di sIL-2R nel trapianto renale. 34
Detection of circulating ICAM-1 and soluble IL-2 receptor in serum of colon cancer patients 34
T-Lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity. 33
The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments 33
Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer 33
Relationships between the activity of MMPI/TIMPI enzymes and the TH1/TH2 cytokine network 33
Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. 33
The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer 33
Functional and phenotipic analysys of lymphocytes from tumor-draining lymph nodes in colon neoplasms 32
Identification of recombination event by DNA heteroduplex in a bone marrow transplant familiar study 32
TNF, IL-6 and soluble IL-2 Receptor in colorectal cancer: comparison of "in vitro" and "in vivo" findings 32
Serum levels of IL-2, soluble IL-2R, TNF, Il-6 in schizophrenic patients: a controlled study 32
Identification of a serum factor interacting with a subset of OKT8+ cells in M.S. 32
Negative association of the HLA-DR 6 antigen in Schizophrenia. 32
CD30: an important costimulator molecule in the regulation of the balance between TH1/TH2 response 31
HLA-DR6 antigen in Schizophrenia 31
Cultured hyppocampal neurons may secrete a compound inhibiting PHA-induced lymph cells proliferation 31
Prognostic Significance of immunological evaluation in colorectal cancer. 31
Inibizione dei neuroni centrali sulla risposta proliferativa delle cellule mononucleate di sangue periferico 31
Serum levels of soluble IL-2 receptor in cancer patients. 31
Presence in multiple sclerosis of serum factors wich modulate "in vitro" reactivity to T8 moAb. 30
The NMDA receptor antagonist AP5 reduces IL-1beta release in anoxic neuronal cultures 30
Cytokine contribution to the repair processess and homeostasis recovery following anoxic insult: a possible IFN regulating role in IL1 neurotoxic action in physiological or damaged CNS 30
Loci Ia-LIKE e risposta alle malattie 29
Identification of factors interacting with a subset of T8+ cells. 29
Soluble Lymphocyte activation molecules in cancer 28
Disease markers in cancer patients: IL-2 receptor 28
Carcinoembryonic antigen and soluble interleukin-2 receptor in colon cancer 28
Disease Stage Prognostic Indices in the Early Clinical Screening of Colorectal Cancer Patients. 27
Predictive effect of neuroleptic treatment on "in vitro" tumor necrosis factor production in schizophrenia. 27
The Directory of On-going Cancer Research in the European Union 27
Totale 4.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.873
article - articoli 10.663
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.302
Totale 27.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202417 0 0 0 0 0 0 0 0 1 2 7 7
2024/20251.841 4 18 107 68 618 110 22 44 43 87 372 348
2025/20262.409 115 206 236 345 383 174 346 126 154 166 109 49
2026/2027390 110 97 183 0 0 0 0 0 0 0 0 0
Totale 4.657